Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move: TSX: $ACB.TO,
NASDAQ: $CRON, TSX: $CRON.TO, CSE: $MYM.C, CSE: $CRZ.C
RCMP, in
partnership with the Canadian Association of Chiefs of Police (CACP) and the
Canadian Police Knowledge Network (CPKN) announce online Training
Delta, Kelowna, BC –August 14 , 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from Aurora Cannabis Inc.
trading on the TSX as ACB and the OTCQB as ACBFF, Cronos Group Inc. trading on
the NASDAQ and TSX as CRON, MYM
Nutraceuticals Inc., trading on the CSE as MYM and CannaRoyalty Corp. trading on the CSE as CRZ.
But first, today, the RCMP, in partnership
with the Canadian Association of Chiefs of Police (CACP) and the Canadian
Police Knowledge Network (CPKN) are announced that the new online training on
cannabis legislation is now available for all Canadian police officers, in both
official languages.
CACP President, Chief Mario Harel, said:
"The CACP is proud to support this proactive initiative and would like to
thank the RCMP and the CPKN for leading the development of this online training
product. With such a significant legislative change coming in October, it was
important for the Canadian law enforcement community to come together, share
resources for a common goal which will benefit communities from coast to coast
to coast."
The online course, entitled Introduction to
Cannabis Legislation, is now available at no cost to all Canadian police
services in Canada on the CPKN portal. The goal of this training is to inform
and educate police officers in Canada on how to consistently apply the new laws
surrounding cannabis.
Upon completion of the course, police officers
will be able to:
·
Identify cannabis in its various forms and
relate it to legal quantities
·
Differentiate between the medical and
non-medical cannabis regimes
·
Recognize criminal offences under the Cannabis Act
·
Articulate the elements and powers of arrest
for each offence under the Cannabis
Act
·
Identify hazards as they relate to
environments involving cannabis
·
Understand how the new Act will impact
policing in Indigenous communities on reserve
·
Make appropriate linkages to other training
related to drug-impaired driving
·
Apply strategies to assist with critical
thinking through unknown or new situations.
CPKN President, Sandy Sweet, explains:
"This initiative could become a best practice for future legislative
changes impacting policing in Canada. Through this partnership, we were able to
achieve a mass distribution of online training at a very low cost, using existing
resources and infrastructure."
Aurora Cannabis Inc. today announced that its acquisition of Anandia
Laboratories Inc. is now complete. The previously announced arrangement, under
the provisions of the Business Corporations Act (British Columbia), means that
among other things, Aurora has now acquired all of the issued and outstanding
shares of Anandia in an all-share transaction.
Anandia is a world-leading cannabis-focused science company, specialized
in genomics, metabolite profiling, plant breeding, disease characterization,
and cultivar certification, as well as providing testing services to producers
and patient-cultivators.
Aurora Cannabis Inc. and Alcanna Inc. also applauded the Ontario
Government on its new plans for the responsible sale of recreational cannabis
products through government-operated online sales, and the private sector.
Aurora and Alcanna have entered into a license agreement which – as soon
as regulations permit – will allow Alcanna to open retail cannabis stores under
the brand name "Aurora". Alcanna has made considerable progress in
preparing for this exciting opportunity and has identified over 100 potential
retail locations throughout the province already. This agreement represents a
significant competitive advantage and will allow for the rapid establishment of
a robust network of cannabis retail stores that comply with all provincial and
municipal requirements, making product, consumer and public safety a top
priority. Together, the two companies have the technology, relationships,
and supply chain and retail expertise to quickly establish themselves in the
Ontario market.
Cronos Group Inc. today announced financial results for the second
quarter ended June 30, 2018.
Some of the highlights included:
·
Cronos Australia was granted a medicinal cannabis Manufacture License by
the Australian Office of Drug Control in June 2018.
·
In June 2018, Cronos entered into a strategic distribution partnership
with Delfarma. Delfarma is a pharmaceutical wholesaler with a distribution network
of over 5,000 pharmacies and more than 200 hospitals that collectively reaches
approximately 40% of the Polish domestic market. Under the five-year exclusive
distribution agreement, Cronos will supply PEACE NATURALS™ branded cannabis
products to Delfarma for distribution within Poland.
·
Cronos Group previewed its premium recreational brand COVE™ at the May
2018 LIFT Conference. COVE™ was born in the Okanagan Valley in British
Columbia, which is known for producing some of the world's finest cannabis. COVE™
products are non-irradiated and hand-trimmed using only the best result of each
harvest. By avoiding shortcuts like harsh refining processes, COVE™ is able to
maintain the natural balance of the plant across all of the brand's terpene
rich cannabis extracts and brings the highest quality products to its
consumers.
·
On May 23, 2018 the trading of Cronos Group's common shares in Canada
were up-listed from the TSX Venture Exchange to the Toronto Stock Exchange
("TSX"). Cronos Group's common shares are listed under the
symbol "CRON" on both the NASDAQ Global Market and the TSX.
·
Cronos strengthened liquidity by raising $100.0 million of gross
proceeds through a bought deal offering of common shares in April 2018. As of
June 30, 2018, total liquidity was $118.0 million, which provides Cronos Group
significant runway to execute on its strategic priorities.
·
Second quarter 2018 revenues totaled $3.4 million, as compared to $0.6
million for the second quarter 2017, representing an increase of $2.8 million,
or 428%. The main drivers associated with the increase in revenues are an
expansion in patient onboarding, an increase in average sales price and the
continued strong growth in our cannabis oil offering.
·
Second quarter 2018 cannabis oil sales accounted for 40% of domestic
medical sales.
·
Finished goods inventory and biological assets increased by 46%
quarter-over-quarter to 2,451 kilograms as the Company focuses on building
inventory for the adult-use market.
CannaRoyalty Corp., a leading North American
cannabis products and brands company, today announced the closing of the
previously announced sale of CannaRoyalty's exclusive Canadian license to use
and commercialize the pre-roll technology developed by Wagner Dimas to Aurora Cannabis
Inc.
CannaRoyalty's exclusive Canadian license to use and commercialize
pre-roll technology developed by Wagner Dimas was valued at $7 million at the
time of the execution of the binding term sheet. The Purchase Price is settled
in 756,348 Aurora Cannabis common shares1, which have now been
issued to the Company. The value of these shares based on the closing price of
Aurora Cannabis common shares on August 13, 2018, was approximately C$4.48
million.
MYM Nutraceuticals Inc., announced it as engaged
well-known tourism and recreational expert, Sylvain Audet, to develop the
concept of the CannaCentre in Weedon, QC. The CannaCentre is associated with
the Company's 1.5 million square foot medical cannabis greenhouse complex
currently under construction in Weedon, Quebec. The CannaCentre will host a
research centre, a training facility, an auditorium for cultural and scientific
activities, a hotel, a restaurant, a medical cannabis interpretation centre and
a medical clinic.
Mr. Audet will work in close collaboration with the Sherbrooke
Historical Society to develop the concept of the medical cannabis museum as
part of the CannaCentre. Mr. Audet is tasked with identifying the primary,
indirect and complementary clientele targets, to suggest services and
activities complementary to the project's infrastructure and evaluate the
profitability of the overall project.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via Spreaker,
iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
